Ambros Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Ambros Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE) (NCT07210515) | Ambros Therapeutics, Inc. | 2026-04-14 |
Track Ambros Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.